Drugs / polycolistin E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06907069 | Jan → Dec 2025 overdue | respiratory tract infectious disorder | First Affiliated Hospital of Ningbo University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polycolistin E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06907069 ↗ |
| Route | Intravenous | “Intravenously atomized polycolistin E sodium mesylate” NCT06907069 ↗ |